Dr. Reddy's Laboratories Limited
RDY
$12.70
-$0.21-1.63%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 13.21% | 10.91% | 8.45% | 10.32% | 9.02% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.21% | 10.91% | 8.45% | 10.32% | 9.02% |
| Cost of Revenue | 10.41% | 8.70% | 7.14% | 5.22% | 2.34% |
| Gross Profit | 15.22% | 12.48% | 9.38% | 14.24% | 14.36% |
| SG&A Expenses | 19.24% | 17.68% | 14.87% | 10.19% | 8.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -0.95% | -16.74% | -3.87% | -51.65% | -38.10% |
| Total Operating Expenses | 15.17% | 13.41% | 11.03% | 7.56% | 4.97% |
| Operating Income | 6.91% | 3.12% | 0.58% | 20.33% | 24.53% |
| Income Before Tax | 3.88% | 6.15% | 10.45% | 15.45% | 34.12% |
| Income Tax Expenses | 6.80% | 9.28% | -3.80% | 2.82% | 22.54% |
| Earnings from Continuing Operations | 2.93% | 5.15% | 15.58% | 19.73% | 38.36% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.48% | 3.48% | 15.58% | 19.73% | 38.36% |
| EBIT | 6.91% | 3.12% | 0.58% | 20.33% | 24.53% |
| EBITDA | 7.55% | 3.89% | 2.32% | 18.97% | 21.97% |
| EPS Basic | 1.32% | 3.25% | 15.15% | 19.32% | 37.90% |
| Normalized Basic EPS | 3.79% | 3.33% | 4.25% | 19.52% | 21.30% |
| EPS Diluted | 1.36% | 3.33% | 15.37% | 19.51% | 38.15% |
| Normalized Diluted EPS | 3.82% | 3.37% | 4.43% | 19.75% | 21.59% |
| Average Basic Shares Outstanding | 0.16% | 0.21% | 0.37% | 0.35% | 0.36% |
| Average Diluted Shares Outstanding | 0.13% | 0.16% | 0.19% | 0.18% | 0.15% |
| Dividend Per Share | -1.03% | -1.03% | -1.03% | -1.03% | 21.93% |
| Payout Ratio | -0.03% | -0.04% | 0.11% | 0.08% | -0.07% |
